PZ Cormay S.A. (WSE:CRM)

Market Cap	45.98M
Revenue (ttm)	87.01M
Net Income (ttm)	-6.31M
Shares Out	84.21M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	92,493
Average Volume	113,500
Open	0.548
Previous Close	0.548
Day's Range	0.530 - 0.550
52-Week Range	0.355 - 0.648
Beta	0.73
RSI	74.16
Earnings Date	Mar 28, 2025

About PZ Cormay

PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents in Poland. It offers testing products for clinical chemistry, electrophoresis, hematology, veterinary, coagulology, blood group serology, immunology, immunochemistry, molecular biology, sampling, oncological surgery, and general analytics, as well as vacuum blood collection system. The company offers its products under the Orphée and Diesse brand names. The company also exports its products to approximately 150 countries, including Germany, Austria, France, Greece, Turkey, Ind...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1985
• Employees: 225
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: CRM

Financial Performance

In 2023, PZ Cormay's revenue was 82.23 million, a decrease of -3.67% compared to the previous year's 85.36 million. Losses were -4.50 million, -35.43% less than in 2022.